Emergent BioSolutions Inc. — Director's Dealing 2015

Jun 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-06-15

Reporting Person: Havey Adam (EVP, Biodefense Divison)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-15	Common Stock	M	15919	$14.67	Acquired	57363	Direct
2015-06-15	Common Stock	S	15919	$31.502	Disposed	41444	Direct
2015-06-15	Common Stock	M	9773	$15.83	Acquired	51217	Direct
2015-06-15	Common Stock	S	9773	$31.665	Disposed	41444	Direct
2015-06-15	Common Stock	S	10606	$31.502	Disposed	30838	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-15	Stock Option	$14.67	M	15919	Disposed	2010-03-11	Common Stock (15919)	Direct
2015-06-15	Stock Option	$15.83	M	9773	Disposed	2019-03-12	Common Stock (9773)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on March 12, 2013.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.055 to $31.77, inclusive.

F4: Consists of an option granted under the company's stock incentive plan on March 13, 2012.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $31.72, inclusive.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.03 to $31.76, inclusive.

F7: The option vested in three equal installments in March 2014, 2015 and 2016

F8: The option vested in three equal installments in March 2013, 2014 and 2015.